Strategies to Overcome Heparins' Low Oral Bioavailability
Even after a century, heparin is still the most effective anticoagulant available with few side effects. The poor oral absorption of heparins triggered the search for strategies to achieve oral bioavailability since this route has evident advantages over parenteral administration. Several approaches...
Saved in:
Main Authors: | Ana Rita Neves (Author), Marta Correia- (Author), Emília Sousa (Author), Madalena Pinto (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advanced delivery strategies facilitating oral absorption of heparins
by: Guihua Fang, et al.
Published: (2020) -
Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach
by: Jelena R. Mitrović, et al.
Published: (2021) -
The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability
by: Jannes van der Merwe, et al.
Published: (2020) -
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
by: Pasquale Paolisso, et al.
Published: (2020) -
Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
by: Janis Kay Shute
Published: (2023)